にきび治療薬市場規模、シェア、成長分析：製品別、タイプ別、投与経路別、年齢層別、流通チャネル別、地域別 - 産業予測 2025年～2032年

にきび治療薬2023年の市場規模は111億米ドルで、予測期間（2025-2032年）のCAGRは8.4%で、2024年の120億3,000万米ドルから2032年には229億4,000万米ドルに成長する見通しです。

にきびは依然として世界で最も蔓延している皮膚疾患の1つであり、さまざまな年齢層の数百万人に影響を与え、効果的な治療に対する大きな需要を牽引しています。皮膚の健康、外見、セルフケアに対する意識の高まりが、ニキビ治療薬への関心を高めています。皮膚科学における絶え間ない研究開発により、先進的な外用・内服治療や併用療法など、革新的で効果的な医薬品が生み出されています。さらに、ストレス、食生活の選択、汚染などの現代的なライフスタイル要因がニキビに関連することが増えており、こうした皮膚の悩みに的を絞った解決策を求める人が増えています。にきびに対する認識とライフスタイルへの影響が収束するにつれ、にきび治療薬の市場は拡大し続け、消費者のために効果的でカスタマイズされた治療オプションが優先されるようになっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩
• 貿易分析
• 顧客と購買基準の分析

にきび治療薬市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 局所用レチノイド
• 経口抗生物質
• 経口レチノイド
• 市販薬（OTC）
• イソトレチノイン
• その他

にきび治療薬市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 炎症性ニキビ
• 非炎症性ニキビ

にきび治療薬市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 局所
• 経口
• 注射

にきび治療薬市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 10歳から17歳
• 18歳から44歳
• 45歳から64歳
• 65歳以上

にきび治療薬市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局
• その他

にきび治療薬市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Johnson & Johnson Services, Inc.（USA）
• GlaxoSmithKline plc（GSK）（United Kingdom）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Bausch Health Companies Inc.（Canada）
• Nestle Skin Health S.A.（Switzerland）
• Bayer AG（Germany）
• Viatris Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• F. Hoffmann-La Roche Ltd（Switzerland）
• LEO Pharma A/S（Denmark）
• Mylan N.V.（USA）
• Mayne Pharma Group Limited（Australia）
• Zydus Lifesciences Limited（India）
• Crown Laboratories（USA）
• Stryke Club（USA）

結論と推奨事項

Acne Medication Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.03 billion in 2024 to USD 22.94 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

Acne remains one of the most prevalent skin conditions worldwide, impacting millions across various age groups and driving significant demand for effective treatments. Growing awareness of skin health, appearance, and self-care is fueling interest in acne solutions. Continuous research and development in dermatology have resulted in innovative and effective medications, including advanced topical and oral treatments, as well as combination therapies. Additionally, modern lifestyle factors such as stress, dietary choices, and pollution are increasingly associated with acne, prompting individuals to seek targeted solutions for these skin concerns. As awareness and lifestyle impacts converge, the market for acne medication continues to expand, prioritizing effective and tailored treatment options for consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Medication market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Medication Market Segments Analysis

Global Acne Medication Market is segmented by Product, Type, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Topical Retinoids, Oral Antibiotics, Oral Retinoids, Over-the-Counter (OTC) Drugs, Isotretinoin and Others. Based on Type, the market is segmented into Inflammatory Acne and Non-inflammatory Acne. Based on Route of Administration, the market is segmented into Topical, Oral and Injectable. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Medication Market

The rising need for effective acne treatment options has led to the launch of numerous products tailored to address this issue, such as retinoids, isotretinoins, and both oral and topical antibiotics. These diverse offerings have significantly contributed to increasing global awareness regarding acne treatments and the various products available to manage it. This heightened awareness, in turn, has been instrumental in driving the growth of the acne medication market, as more individuals seek solutions for their skin concerns. As a result, the market is expanding rapidly, catering to the increasing demand for effective acne care solutions.

Restraints in the Acne Medication Market

Although chronic acne is a widespread issue globally, the expansion of the acne medication market faces several challenges. A significant hurdle is the side effects linked to various acne treatment medications. Research by the National Center for Biotechnology Information (NCBI) indicates that around 7% of individuals using tetracycline and 4% of those on macrolides report adverse effects, including nausea, vomiting, and diarrhea. These reactions can deter patients from seeking treatment and adhering to prescribed regimens, ultimately restraining the market's growth potential and limiting the effectiveness of available therapeutic options.

Market Trends of the Acne Medication Market

The global acne medication market is witnessing robust expansion, propelled by a surge in awareness regarding skincare and rising acne prevalence among teenagers and adults alike. Factors such as hormonal fluctuations and lifestyle choices-characterized by increased stress and dietary changes-are contributing to acne incidences. Furthermore, the growing trend of proactive skincare regimes among consumers is driving the adoption of specialized acne treatments, including topical solutions and oral medications. Innovations in formulation, including natural and cruelty-free products, are also aligning with consumer preferences, bolstering market penetration. As a result, the acne medication market is projected to sustain its upward trajectory in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement
• Trade Analysis
• Customer & Buying Criteria Analysis

Global Acne Medication Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Retinoids
• Oral Antibiotics
• Oral Retinoids
• Over-the-Counter (OTC) Drugs
• Isotretinoin
• Others

Global Acne Medication Market Size by Type & CAGR (2025-2032)

• Market Overview
• Inflammatory Acne
• Non-inflammatory Acne

Global Acne Medication Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Topical
• Oral
• Injectable

Global Acne Medication Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Medication Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Acne Medication Market Size & CAGR (2025-2032)

• North America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEO Pharma A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryke Club (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations